Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 14 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-01 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2023-03-01 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Grant or award +50,000 50,000
2023-01-27 Hare Joshua Chief Scientific Officer Sale −20,000 $4.28 $86K 7,793,263
2023-01-03 Lehr Paul T General Counsel, Secretary Shares withheld for taxes −1,472 $3.37 $5K 147,042
2023-01-03 Clavijo James CFO and Treasurer Shares withheld for taxes −1,288 $3.37 $4K 75,649
2022-12-21 Borger Erin Director Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-21 Hare Neil E Director Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-21 Soffer Rock Director Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-21 Ross Cathy Director Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-21 Hare Joshua Chief Scientific Officer Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-21 LOSORDO DOUGLAS W Director Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-21 Ungaro Ursula Director Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-21 Soffer Donald M Director Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-21 Girolamo Todd C Director Grant or award · Stock Option (Right to buy) +5,000 5,000
2022-12-02 Hare Joshua Chief Scientific Officer Sale −20,000 $3.74 $75K 7,813,263
2022-11-16 Lehr Paul T General Counsel, Secretary Grant or award · Employee Stock Option (right to buy) +22,843 22,843
2022-11-16 Hare Joshua Chief Scientific Officer Grant or award +48,140 7,861,403
2022-10-12 Hare Joshua Chief Scientific Officer Sale −100,000 $3.61 $361K 7,813,263
2022-10-03 Clavijo James CFO and Treasurer Shares withheld for taxes −1,256 $3.75 $5K 76,937
2022-10-03 Lehr Paul T General Counsel, Secretary Shares withheld for taxes −1,435 $3.75 $5K 148,514

Page 11 of 14 · 271 trades